| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
5e-11 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-09 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
2e-09 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
7e-09 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
9e-09 |
| mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-08 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-08 |
| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-08 |
| mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-08 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-08 |